Patients wave goodbye to breast cancer drugs
A third of post-menopausalAfter the menopause - technically only once a woman has had no menstrual period for one year. breast cancerAbnormal, uncontrolled cell division resulting in a malignant tumour that may invade surrounding tissues or spread to distant parts of the body. patients stop taking their medication due to the side effects. Women in both the USA and the UK are found to stop their treatment early as the longer the women are treated, the more side effects they experience.
The Northwestern University in the USA questioned 700 women who were being treated with aromatase inhibitors. They found that within four years, 36% of those being treated with the drugs had stopped taking them due to the ‘unbearable’ side effects. Side effects of aromatase inhibitors include weight gain, hot flushes, a drop in libidoSexual drive. and severe joint pain. The aromatase inhibitors are used to treat breast cancer and ovarianrelating to the ovaries cancer in post-menopausal women by reducing production of oestrogenA hormone involved in female sexual development, produced by the ovaries. and blocking its action.
Women who had been treated using chemotherapyThe use of chemical substances to treat disease, particularly cancer. or radiotherapyThe treatment of disease using radiation. were the most likely to stop their medication due to the combination of side effects from the different treatments. Dr Wagner, who led the study stated that “Clinicians consistently underestimate the side-effects associated with treatment.”







